(AP) Novo Nordisk, the maker of Ozempic and Wegovy, announced on Monday that it plans to add 1,000 jobs when another company manufacturing plant is built in a suburb of North Carolinas capital to expand production of the very popular weight loss and diabetes medicines, as well as other treatments
Close monitoring during dose transitions is essential
Rachel Hall, Principal Doctor at Second Nature Our research at Second Nature shows that fatigue typically follows a predictable pattern: Weeks 1-4: Nearly half of patients (44%) report increased tiredness Weeks 5-8: Fatigue significantly improves, with only 22% still reporting tiredness Beyond week 12: Most patients return to normal energy levels as the body adapts For some patients, tiredness can persist longer, particularly if theyre not consuming adequate nutrition or have underlying issues like poor sleep habits or nutrient deficiencies
The lack of pharmacological overlap between tirzepatide and lupus biologics is actually one of the strongest arguments for its safety in this population
What does clinical evidence say about GLP-1 medications and birth defects
That curiosity has put semaglutide and its cousins in the same conversation as naltrexone, a medication that has been reducing alcohol cravings for people for decades